Teh Seng Pharmaceutical Mfg Co (ROCO:7860) Research & Development: NT$16.1 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7860 Teh Seng Pharmaceutical Mfg Co Ltd ROCO:7860
23 GF Score
Price NT$77.60
! 7 Warning Signs
View Full Analysis

What is Teh Seng Pharmaceutical Mfg Co Research & Development?

Teh Seng Pharmaceutical Mfg Co ROCO:7860 -4.79% 23 Research & Development is NT$16.1 Mil as of Dec. 2025. GuruFocus rates ROCO:7860 with a GF Score™ of 23/100. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Teh Seng Pharmaceutical Mfg Co's Research & Development for the six months ended in Dec. 2025 was NT$8.9 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$16.1 Mil.

Teh Seng Pharmaceutical Mfg Co  (ROCO:7860) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Teh Seng Pharmaceutical Mfg Co Research & Development Related Terms

Teh Seng Pharmaceutical Mfg Co Research & Development Historical Data

* Premium members only.

The historical data trend for Teh Seng Pharmaceutical Mfg Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teh Seng Pharmaceutical Mfg Co Research & Development Chart

Teh Seng Pharmaceutical Mfg Co Annual Data
Trend Dec23 Dec24 Dec25
Research & Development
18.92 15.20 16.09

Teh Seng Pharmaceutical Mfg Co Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development 0.00 6.98 8.22 7.22 8.87
ROCO:7860
23GF Score
Teh Seng Pharmaceutical Mfg Co Ltd ROCO:7860
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teh Seng Pharmaceutical Mfg Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$16.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$16.1 Mil mean?
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a Research & Development of NT$16.1 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Teh Seng Pharmaceutical Mfg Co and its competitors.
Is Teh Seng Pharmaceutical Mfg Co's Research & Development too high?
Teh Seng Pharmaceutical Mfg Co's current Research & Development is NT$16.1 Mil. Overall, Teh Seng Pharmaceutical Mfg Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Teh Seng Pharmaceutical Mfg Co's Research & Development compare to ZTS and UTHR?
Teh Seng Pharmaceutical Mfg Co's Research & Development of NT$16.1 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Teh Seng Pharmaceutical Mfg Co and its competitors. Teh Seng Pharmaceutical Mfg Co's current Research & Development is NT$16.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teh Seng Pharmaceutical Mfg Co stock overvalued right now?
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a current Research & Development of NT$16.1 Mil. The current Research & Development is NT$16.1 Mil. Teh Seng Pharmaceutical Mfg Co's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Teh Seng Pharmaceutical Mfg Co (ROCO:7860), the current Research & Development is NT$16.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Teh Seng Pharmaceutical Mfg Co Business Description

Address No.42,Huan Gong Road, Yong Kang District, Tainan, TWN, 710001
Teh Seng Pharmaceutical Mfg Co Ltd is engaged in the development and manufacturing of various pain relieving patches, cosmetic patches and biotechnology products. Its products include: Hydrogel Patches, Oil-Based Patches, Hot-Melt Patches, CMO & CRO for Transdermal Patch, Oral Film & Sublingual, Cosmetic Patches, Biotechnology Products and Daily Supplements.
23GF Score

Get the complete analysis for ROCO:7860

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$77.60
Price